Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
depression
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
What Mood Symptoms may be most Difficult to Rate?
$
30.00
Add to cart
Details
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Efficacy of Omega-3 Fatty Acids in Mood Disorders
$
30.00
Add to cart
Details
Depression Rating Scales – A Doctor’s Guide
$
15.00
Add to cart
Details
Boadie W. Dunlop – Exercise for Depression: Efficacy, Safety and Clinical Trial Implications
$
30.00
Add to cart
Details
Aliza P. Wingo – Frequency of Stimulant Treatment and of Stimulant-Associated Mania/Hypomania in Bipolar Disorder Patients
$
30.00
Add to cart
Details
Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening
$
30.00
Add to cart
Details
Risperidone: Review of Its Therapeutic Utility in Depression
$
30.00
Add to cart
Details
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
$
30.00
Add to cart
Details
New Developments in the Neurobiological Basis of Anxiety Disorders
$
30.00
Add to cart
Details
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Depression in the Elderly
$
30.00
Add to cart
Details
Depression Treatment: A Lifelong Commitment?
$
30.00
Add to cart
Details
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
$
30.00
Add to cart
Details
New Developments in Depression and Anxiety Disorders
$
30.00
Add to cart
Details
Remission as the Critical Outcome of Depression Treatment
$
30.00
Add to cart
Details
Long-Term Antidepressant Treatment
$
30.00
Add to cart
Details
Strategies for Treatment-Resistant Depression
$
30.00
Add to cart
Details
Gender-Specific Differences in Depression and Treatment Response
$
30.00
Add to cart
Details
Management of Late-Life Depression: Focus on Comorbid Conditions
$
30.00
Add to cart
Details
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
$
30.00
Add to cart
Details
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Paroxetine Treatment of Depression in Late Life
$
30.00
Add to cart
Details
Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?
$
30.00
Add to cart
Details
Androgens and the Aging Male
$
30.00
Add to cart
Details
P. Murali Doraiswamy, MD: A Randomized Controlled Trial of Paroxetine for Noncardiac Chest Pain
$
30.00
Add to cart
Details
Mark Zetin, MD: Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients
$
30.00
Add to cart
Details
Gwenn S. Smith, PhD: Applications of Neuroreceptor Imaging to Psychiatry Research
$
30.00
Add to cart
Details
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
$
30.00
Add to cart
Details
Alexander Neumeister, MD: Tryptophan Depletion, Serotonin, and Depression: Where Do We Stand?
$
30.00
Add to cart
Details
Gregory M. Asnis, MD: IFN-Induced Depression: A Role for NSAIDs
$
30.00
Add to cart
Details
Graeme F. Mason, PhD: Magnetic Resonance Spectroscopy for Studies of Neurotransmission in Vivo
$
30.00
Add to cart
Details
Paolo Castrogiovanni, MD: Can Serotonin and Fluoxetine Levels in Plasma and Platelets Predict Clinical Response in Depression?
$
30.00
Add to cart
Details
J. Douglas Bremner, MD: Does Isotretinoin Cause Depression and Suicide?
$
30.00
Add to cart
Details
Patricia R. Houck, MSH: An Intent-to-Treat Method for Enhancing Analysis of Clinical Trials with Rescue Medication: A Mixed-Model Approach
$
30.00
Add to cart
Details
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: Duloxetine for the Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Donald S. Robinson, MD: Monoamine Oxidase Inhibitors: A New Generation
$
30.00
Add to cart
Details
Gregory J. Moore, PhD: Magnetic Resonance Spectroscopy: Neurochemistry and Treatment Effects in Affective Disorders
$
30.00
Add to cart
Details
David C. Steffens, MD, MHS: The Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED) Approach
$
30.00
Add to cart
Details
Theodore J. Anfinson, MD: Akathisia, Panic, Agoraphobia, and Major Depression Following Brief Exposure to Metoclopramide
$
30.00
Add to cart
Details
Jay D. Kranzler, MD, PhD: The Psychopharmacology of Fibromyalgia: A Drug Development Perspective
$
30.00
Add to cart
Details
Joyce E. Myers, MD: Risperidone: Review of Its Therapeutic Utility in Depression
$
30.00
Add to cart
Details
Lydia Lewis: Mood Disorders: Diagnosis, Treatment, and Support From a Patient Perspective
$
30.00
Add to cart
Details
Merry N. Miller, MD: Premenstrual Exacerbations of Mood Disorders
$
30.00
Add to cart
Details
Tyler M. McLeod, BS: Nitric Oxide, Stress, and Depression
$
30.00
Add to cart
Details
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
$
30.00
Add to cart
Details
Antidepressant Induced Apathy Responsive to Dose Reduction
$
30.00
Add to cart
Details
Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy
$
30.00
Add to cart
Details
Placebo Response in Depression: A Perspective for Clinical Practice
$
30.00
Add to cart
Details
Claus Rosenberg, MD: Citalopram Versus Amitriptyline in Elderly Depressed Patients with or without Mild Cognitive Dysfunction: A Danish Multicentre Trial in General Practice
$
30.00
Add to cart
Details
Center for Epidemiologic Studies Depression Scale (CES-D)
$
0.00
Add to cart
Details
Clinical Global Impressions (CGI)
$
0.00
Add to cart
Details
The Hamilton Rating Scale for Depression
$
0.00
Add to cart
Details
Sexual Pain among Malaysian Women Receiving Antidepressant: A Comparison between Escitalopram and Fluoxetine
$
30.00
Add to cart
Details
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
$
30.00
Add to cart
Details
Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 47 No. 2, 2017 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$
0.00
Add to cart
Details
1
2
Next
Page load link
Go to Top
